DIAGNOSTIC ACCURACY OF CT VIRTUAL CYSTOSCOPY IN DETECTING URINARY BLADDER CARCINOMA
Main Article Content
Keywords
Bladder Cancer, CT Virtual Cystoscopy, Conventional Cystoscopy, Diagnostic Accuracy, Non-Invasive Imaging, Sensitivity and Specificity, Urinary Tract Neoplasms
Abstract
Background: Urinary bladder carcinoma is a prevalent malignancy worldwide, requiring early and accurate detection for effective management. Conventional cystoscopy is the gold standard for diagnosis but is invasive, associated with discomfort, and carries procedural risks. CT Virtual Cystoscopy (CTVC) has emerged as a promising, non-invasive imaging technique for detecting bladder carcinoma.
Objectives: The aim of current study was to evaluate the diagnostic accuracy of CTVC in detecting urinary bladder carcinoma using conventional cystoscopy as the gold standard.
Methods: This cross-sectional validation study was conducted at Faisalabad Medical University and Allied Hospital, enrolling n=95 patients aged 25–70 years presenting with gross painless hematuria. All patients underwent CTVC followed by conventional cystoscopy for comparison. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy were calculated using a 2×2 contingency table. Stratification was performed based on age and gender, and a p-value ≤ 0.05 was considered statistically significant.
Results: CTVC demonstrated a sensitivity of 86.49%, specificity of 93.10%, PPV of 88.89%, and NPV of 91.53%, with an overall accuracy of 90.53%. Stratified analysis revealed 100% accuracy in patients aged 25–55 years and 90.62% accuracy in those aged 56–70 years. Gender-based stratification showed slightly higher accuracy in female patients (94.12%) than in males (89.74%).
Conclusion: CT Virtual Cystoscopy is a highly accurate, non-invasive diagnostic modality for detecting urinary bladder carcinoma, offering a viable alternative to conventional cystoscopy. Given its high sensitivity, specificity, and diagnostic accuracy, CTVC can be integrated into routine clinical practice for early detection and follow-up of bladder cancer patients. Future research should focus on multi-center trials, AI-assisted imaging, and biomarker integration to further enhance diagnostic efficiency.
References
2. MondoniM, SotgiuG, BonifaziM, et al. Transbronchial needle aspiration in peripheral pulmonary lesions: a systematic review and meta-analysis. EurRespirJ 2016; 48: 196-204. [PubMed] [Google Scholar]
3. SteinfortDP, KhorYH, ManserRL, Irving LB. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. EurRespirJ 2011; 37: 902-910. [PubMed] [Google Scholar]
4. Ali MS, Trick W, MbaBL, MohananeyD, SetniJ, MusaniA. Radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions: A systematic review and meta-analysis. Respirology2017; 22: 443-453. [PubMed] [Google Scholar]
5. Zhan P, Zhu QQ, MiuYY, et al. Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: A systematic review and meta-analysis. Trans Lung Cancer Res 2017; 6: 23-34. [PMC free article] [PubMed] [Google Scholar]
6. Fielding DI, Chia C, Nguyen P, et al. Prospective randomized trial of endobronchial ultrasound-guide sheath versus computed tomography-guided percutaneous core biopsies for peripheral lung lesions. Intern Med J 2012; 42: 894-900. [PubMed] [Google Scholar]
7. Han Y, Kim HJ, Kong KA, et al. diagnosis of small pulmonary lesions by transbronchial lung biopsy with radial endobronchial ultrasound and virtual bronchoscopic navigation versus CT-guided transthoracic needle biopsy: A systematic review and meta-analysis. PLoSOne 2018; 13: e0191590. [PMC free article] [PubMed] [Google Scholar]
8. HurJ, Lee HJ, Nam JE, et al. Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of ground-glass opacity pulmonary lesions. Am J Roentgenol2009; 192: 629-634. [PubMed] [Google Scholar]